If approved, marstacimab would be the first non-factor prophylactic treatment indicated for pediatric patients aged 6 to 11 years with hemophilia B.

Updated FDA labeling for Yescarta now includes patients with relapsed or refractory primary CNS lymphoma, expanding treatment options for this group.

Combo treatment aims to be latest to enter the weight loss space; Amgen refuses to remove drug from market despite FDA request; Novo Nordisk threatens legal action against Hims & Hers; an oral film ...

HealthDay News — New Mexico health officials are urging residents to avoid raw milk after a newborn died from listeria, a dangerous foodborne illness.

The mean percent change in LDL cholesterol levels at week 24 was −57.1 and 3.0% with enlicitide and placebo, respectively.

Review finds no evidence supporting CDC changes to newborn hepatitis B vaccine guidelines; universal birth dose remains the safest strategy.

It takes only 3 cases of measles for health officials to declare an outbreak. So far in 2026, at least 17 states have reported infections, according to the US Centers for Disease Control and ...

Residual lung abnormalities were consistent with elevated epithelial injury biomarkers, profibrotic signaling.

A new $100 million pilot program will support people who are homeless and struggling with addiction or mental illness ...

Novo Nordisk addresses deceptive advertising by Hims & Hers regarding unapproved GLP-1 products as oral Wegovy remains in full supply in the US.

Vybrique is an oral film formulation of sildenafil, a phosphodiesterate-5 inhibitor, designed to dissolve on the tongue without the need for food or water.

Investigational antiviral pritelivir demonstrates efficacy and improved tolerability over current treatments for refractory HSV in high-risk patients.